Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.
about
Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative reviewHow Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores"Pre-exposure prophylaxis for sexually-acquired HIV risk management: a reviewAttitude towards antiretroviral Pre-Exposure Prophylaxis (PrEP) prescription among HIV specialists.High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, PeruPrescribing of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis by HIV Medical Providers in the United States, 2013-2014Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in MassachusettsHIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative studyPreparing for PrEP: perceptions and readiness of canadian physicians for the implementation of HIV pre-exposure prophylaxis.Antiretroviral chemoprophylaxis: state of evidence and the research agenda.Acceptability and willingness among men who have sex with men (MSM) to use a tablet-based HIV risk assessment in a clinical setting.Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships.Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryKnowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England.PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEPAwareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementationThe preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA.From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.Preferences for HIV pre-exposure prophylaxis (PrEP) information among men-who-have-sex-with-men (MSM) at community outreach settings.Framing HIV Pre-Exposure Prophylaxis (PrEP) for the General Public: How Inclusive Messaging May Prevent Prejudice from Diminishing Public Support.Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in YouthInitiation of antiretroviral therapy in youth with HIV: a U.S.-based provider survey.Engaging healthcare providers to implement HIV pre-exposure prophylaxis.Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers.What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review.Incorporating couples-based approaches into HIV prevention for gay and bisexual men: opportunities and challenges.The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.Factors Related to Pre-exposure Prophylaxis Prescription by U.S. Primary Care Physicians.Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.Healthcare Provider Contact and Pre-exposure Prophylaxis in Baltimore Men Who Have Sex With Men.PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection.Attitudes toward HIV pre-exposure prophylaxis among men who have sex with men in western China.PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists.A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians.Low Awareness and Use of Preexposure Prophylaxis in a Diverse Online Sample of Men Who Have Sex With Men in New York City.
P2860
Q26778293-4E09D42A-FD24-4194-889F-5C5F6C64989EQ26798250-07BEBDCD-1E79-4998-95CA-A81C45210083Q26849762-687A700D-17F3-40F4-BB5C-6BC9A9EAD62FQ30539971-01CA82D4-8511-4E52-A7F0-D10D25D986DCQ30877918-2C08FAD3-BFBE-498D-B678-DC9B8235E20DQ33566562-12E04A0E-E7DA-4127-97B7-B6E9A3BE8FB8Q33629173-DD6CF018-A24A-4300-A628-04C9F9F290C1Q33739550-DB598EA8-2C81-4039-8C07-1FD213AAB8C4Q34022199-2269FEBE-332D-4F12-B936-31292D5A1741Q34061718-1B830BF7-3BE6-478C-A574-E8A68FCCE537Q34077715-E6207DB0-009E-4F2A-847E-E63450F5D35EQ34697242-8937D3EA-6EDE-4FDC-86DB-27083CABFB8FQ35085850-13023F9E-7673-4CD7-8DF1-44B654781290Q35541521-2F1BAB9F-67DF-4C7A-9095-DCAC3900566EQ35561629-B03171A0-3E58-4D90-8509-75EAC6C1D322Q35683071-5D5A75D4-756B-42FA-AF56-FAB8BD62F396Q36040025-B1B3E7EB-E61F-469B-A2A4-B0FDC9D7F139Q36053059-E03071E2-4599-4F10-91F7-FDC5AC6C42EFQ36278936-045767B9-1467-4A20-8A8E-EF148804F907Q36296707-39D90F40-6C3D-4EF6-962E-4C8361FF2B2AQ36348296-33308CE9-365C-4E1D-84D2-BB9BC6293716Q36760768-96579C23-CAA6-4024-BDFE-973F4E401CF8Q36788026-000F3A6F-FC71-40F4-B15D-E4308D790A54Q36995385-A5FCFAC6-88E7-45F1-A413-ACD4F17D3342Q37102113-106714CB-23BA-4B34-BB89-25CF13FB7468Q37139616-87BFC936-53FA-43B7-990A-8DAA5E5D20F8Q37161853-B5D5D9C2-0B78-49BB-90AB-B0BFBA835582Q37176014-1C727094-CCF9-462C-85BF-4F87B798B178Q37215398-BA88F542-3F93-4D80-8BD6-B26967F038E8Q37572966-323DDD27-1F05-4133-916F-45823BBA1590Q37697216-01266361-637B-473E-B70C-47E4E868CDEAQ37736077-FD92D209-3130-4CF8-AA7A-8C9FAFF389F7Q38864273-CB317C98-71E0-4ED4-BC45-82F2FEB3A820Q38985811-F291F474-ABF1-4E7F-AEDA-E3585A78101CQ39357161-FDC705BB-0E31-4C45-880A-F0164E865BCDQ40126361-E1A36752-FAE4-4A28-BC99-8C82FDD2F014Q42563311-6BD08BF7-8514-47DE-B775-6C3B394FA5ACQ47140463-B311E49A-3E61-4266-B797-B36FED9B94CCQ50330676-2388A7D9-1D03-41B1-A21D-3EEB8E5BC66BQ54912930-83E8CB17-7DEA-4A91-B4AC-F6B184F4AFAC
P2860
Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@ast
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@en
type
label
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@ast
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@en
prefLabel
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@ast
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@en
P2860
P356
P1476
Evolution of Massachusetts phy ...... etrovirals for HIV prevention.
@en
P2093
Douglas S Krakower
Jaclyn M White
P2860
P304
P356
10.1089/APC.2012.0030
P577
2012-06-13T00:00:00Z